Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33.9M
-
Number of holders
-
116
-
Total 13F shares, excl. options
-
20.1M
-
Shares change
-
+1.77M
-
Total reported value, excl. options
-
$385M
-
Value change
-
+$27.4M
-
Put/Call ratio
-
1.17
-
Number of buys
-
56
-
Number of sells
-
-50
-
Price
-
$19.16
Significant Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q4 2021
146 filings reported holding TMDX - TransMedics Group, Inc. - Common Stock as of Q4 2021.
TransMedics Group, Inc. - Common Stock (TMDX) has 116 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.1M shares
of 33.9M outstanding shares and own 59.16% of the company stock.
Largest 10 shareholders include FMR LLC (4.17M shares), BlackRock Inc. (1.9M shares), Sandhill Capital Partners LLC (1.81M shares), MACQUARIE GROUP LTD (1.65M shares), CREDIT SUISSE AG/ (1.52M shares), VANGUARD GROUP INC (1.33M shares), STATE STREET CORP (818K shares), Bank of New York Mellon Corp (636K shares), Bellevue Group AG (581K shares), and KORNITZER CAPITAL MANAGEMENT INC /KS (467K shares).
This table shows the top 116 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.